P-glycoprotein-mediated drug efflux is a resistance mechanism of chronic myelogenous leukemia cells to treatment with imatinib mesylate by Illmer T, Schaich M, Platzbecker U, Freiberg-Richter J, Oelschl├Ągel U, von Bonin M, Pursche S, Bergemann T, Ehninger G, Schleyer E in Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K (2004).

[PMID: 14724652] PubMed

Abstract

Discussed In Paper

Loading...

Dosing Information

No dosing information annotated.